支气管肺泡灌洗液与支气管冲洗液多重核酸检测对呼吸道病毒的诊断性能
该回顾性研究纳入170例患者共184对同时采集的支气管肺泡灌洗液(BAL)与支气管冲洗液(BW)标本,评估多重核酸扩增检测(NAT)的诊断性能。BW标本与联合检测结果的总体符合率为98.9%(95%CI 95.5–98.9%),BAL为96.7%(95%CI 93.0–96.7%),两者性能等效,且同时检测多种下呼吸道标本的额外获益有限。
要点
- BW与BAL标本的多重NAT结果高度一致(94.6%完全一致)。
- BW标本阳性符合率(95.0%)高于BAL(85.0%)。
- BW检测性能与BAL等效,额外检测应权衡成本与并发症。
核心结论
- 同时采集的BAL与BW标本多重NAT结果高度一致,BW检测性能与BAL等效。
- 对同一患者单次感染同时检测多种下呼吸道标本的额外获益有限,需权衡成本与风险。
研究设计与样本
- 最终队列170例患者,184对同时采集(4小时内接收)的BAL与BW标本。
- 中位年龄58岁,男性占62%。
主要发现
- BW标本与联合检测的总体符合率为98.9%(95%CI 95.5–98.9%),BAL为96.7%(95%CI 93.0–96.7%)。
- BW标本阳性符合率为95.0%,BAL为85.0%;BW额外识别4份标本。
- 174份标本(94.6%)结果完全一致,其中阴性144份、阳性34份。
临床怎么用
- BW标本可作为BAL的等效替代用于多重NAT检测呼吸道病原体。
- 临床决定是否同时送检BAL和BW时,应综合考虑潜在并发症与医疗成本。
局限性
- 回顾性研究设计,样本量有限(170例患者)。
- 仅纳入同时采集(4小时内)的标本,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is limited knowledge on the yield of performing multiplex nucleic acid testing (NAT) on multiple lower respiratory tract specimens from a single patient with a single instance of infection. We evaluated the performance characteristics of multiplex NAT assays performed concurrently on bronchoalveolar lavage (BAL) and bronchial wash (BW) specimens to detect respiratory pathogens. A retrospective study of admitted patients from March 2013 through December 2016 was performed. Individual performance characteristics of BAL and BW specimens were compared to positive results from either set of specimens. Only contemporaneous BAL and BW specimens (received by the laboratory within 4 h of each other) were included. The final cohort included 170 patients, with 184 contemporaneous BAL and BW specimens submitted for multiplex NAT (median age, 58 years; 62% male). Of the patients with positive NAT results, 38 of 40 BW specimens tested positive (overall percent agreement with combined testing, 98.9%; 95% confidence interval [CI], 95.5 to 98.9%), and 34 of 40 BAL specimens tested positive (overall percent agreement with combined testing, 96.7%; 95% CI, 93.0 to 96.7%). Assays performed on BW specimens identified 4 additional specimens and had a higher positive percent agreement (95.0%) with combined testing results compared to those performed on BAL specimens (85.0%). There was exact concordance in 174 specimens (94.6%; negative and positive for respiratory pathogens, 144 and 34 specimens, respectively). We observed high concordance (95%) between multiplex NAT results from contemporaneous BAL and BW specimens. Performance characteristics of BW specimen testing were equivalent to those of BAL specimen testing. The benefit of performing additional testing should be carefully considered against the potential complications and health care costs.
引用
- Munigala S, Burnham CA, Anderson NW, et al. Diagnostic Performance of Multiplex Nucleic Acid Testing of Bronchoalveolar Lavage and Bronchial Wash Specimens for Respiratory Viral Pathogens. J Clin Microbiol. 2018. PMID: 30093393. doi:10.1128/JCM.00973-18
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。